Network coordinating care and work on chronic pancreatitis, pancreatitis-related diabetes, and pancreatic cancer
Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC)
This program brings together hospitals to collect medical information and samples from people with chronic pancreatitis, pancreatitis-related diabetes, and pancreatic cancer to speed better tests and treatments.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11212226 on NIH RePORTER |
What this research studies
This coordinating center runs a national network that enrolls people with chronic or recurrent pancreatitis, pancreatitis-related diabetes, and pancreatic cancer at multiple medical centers. Participants have clinic visits, medical record reviews, imaging and lab tests, and may donate blood or tissue samples to a shared biobank. The center organizes data collection, quality control, and links clinical information with biospecimens so researchers can look for patterns, biomarkers, and treatment targets over time. It supports multicenter efforts (for example PROCEED, INSPPIRE2, NOD, and DETECT) to make findings comparable across hospitals and speed discoveries.
Who could benefit from this research
Good fit: Ideal candidates are people seen at participating sites with chronic or recurrent pancreatitis, pancreatitis-related (pancreatogenic) diabetes, or a diagnosis or high risk of pancreatic cancer who can attend follow-up at a consortium clinic.
Not a fit: People without pancreatic disease, those seeking an immediate new therapy, or those unable to visit participating centers are unlikely to benefit directly from this coordination-focused program.
Why it matters
Potential benefit: If successful, this work could lead to earlier diagnosis, better biomarker tests, and more effective treatments for pancreatitis-related complications, pancreatogenic diabetes, and pancreatic cancer.
How similar studies have performed: Earlier CPCRC multicenter efforts such as PROCEED and INSPPIRE2 have successfully collected long-term data and biospecimens and yielded new insights, although new treatments remain limited and more work is needed.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Li, Liang — University of Tx Md Anderson Can Ctr
- Study coordinator: Li, Liang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.